SenzaGen AB

SENZA · Nasdaq Stockholm · Healthcare

4.53SEK −1.1%last day

Price as of 2 October 2026

The price over the past year, with dividends: −24.5%

Performance

1 month

−9.2%

1 year

−24.5%

3 years, per year

−18.1%

5 years, per year

−21.3%

Largest fall, 3 years

−77.2%

Below the peak now

−93.5%

Volatility, 1 year

37.2%

Return with dividends reinvested.

Key figures

P/E

negative earnings

P/B

1.6

Dividend yield

0.0%

Return on equity

−11.9%

Net margin

−17.5%

Market value

15 m USD

Quality, value and trend

Where SenzaGen stands against every Nordic stock today. 100 is best.

Quality66

Profitability and a sound balance sheet over time. Better than 66% of Nordic stocks.

Value34

The price measured against earnings, assets and cash flow. Better than 34% of Nordic stocks.

Trend17

The price development over the past year. Better than 17% of Nordic stocks.

Combined27

Quality, value and trend together. Better than 27% of Nordic stocks.

About SenzaGen

SenzaGen AB is a company in healthcare, listed on Nasdaq Stockholm. The share trades in SEK. It has around 34 employees.

SenzaGen AB provides non-animal tests for assessing allergenicity. The company offers GARD skin OECD 442E, GARD skin dose-response, GARD skin medical device; and GARD air, a respiratory sensitization assessment. It also provides biological evaluation, in vitro biocompatibility testing, cytotoxicity, irritation, and skin sensitization medical device services; advisory services for medical devices; and substance based medical devices.

See the full analysis in InvestWiser.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

See the full analysis